• Something wrong with this record ?

Pleomorphic Xanthoastrocytoma: Multi-Institutional Evaluation of Stereotactic Radiosurgery

AH. Düzkalir, Y. Samanci, AM. Nabeel, WA. Reda, SR. Tawadros, K. Abdelkarim, AMN. El-Shehaby, RM. Emad, N. Martínez Moreno, R. Martínez Álvarez, D. Mathieu, A. Niranjan, LD. Lunsford, Z. Wei, RM. Shanahan, R. Liscak, J. May, A. Dono, AI. Blanco,...

. 2025 ; 96 (2) : 416-425. [pub] 20240628

Language English Country United States

Document type Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc25010145

BACKGROUND AND OBJECTIVES: Pleomorphic xanthoastrocytoma (PXA) is a rare low-grade glial tumor primarily affecting young individuals. Surgery is the primary treatment option; however, managing residual/recurrent tumors remains uncertain. This international multi-institutional study retrospectively assessed the use of stereotactic radiosurgery (SRS) for PXA. METHODS: A total of 36 PXA patients (53 tumors) treated at 11 institutions between 1996 and 2023 were analyzed. Data included demographics, clinical variables, SRS parameters, tumor control, and clinical outcomes. Kaplan-Meier estimates summarized the local control (LC), progression-free survival, and overall survival (OS). Secondary end points addressed adverse radiation effects and the risk of malignant transformation. Cox regression analysis was used. RESULTS: A total of 38 tumors were grade 2, and 15 tumors were grade 3. Nine patients underwent initial gross total resection, and 10 received adjuvant therapy. The main reason for SRS was residual tumors (41.5%). The median follow-up was 34 months (range, 2-324 months). LC was achieved in 77.4% of tumors, with 6-month, 1-year, and 2-year LC estimates at 86.7%, 82.3%, and 77.8%, respectively. Younger age at SRS (hazard ratios [HR] 3.164), absence of peritumoral edema (HR 4.685), and higher marginal dose (HR 6.190) were significantly associated with better LC. OS estimates at 1, 2, and 5 years were 86%, 74%, and 49.3%, respectively, with a median OS of 44 months. Four patients died due to disease progression. Radiological adverse radiation effects included edema (n = 8) and hemorrhagic change (n = 1). One grade 3 PXA transformed into glioblastoma 13 months after SRS. CONCLUSION: SRS offers promising outcomes for PXA management, providing effective LC, reasonable progression-free survival, and minimal adverse events.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010145
003      
CZ-PrNML
005      
20250429134753.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1227/neu.0000000000003083 $2 doi
035    __
$a (PubMed)38940575
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Düzkalir, Ali Haluk $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey $1 https://orcid.org/0000000225359832
245    10
$a Pleomorphic Xanthoastrocytoma: Multi-Institutional Evaluation of Stereotactic Radiosurgery / $c AH. Düzkalir, Y. Samanci, AM. Nabeel, WA. Reda, SR. Tawadros, K. Abdelkarim, AMN. El-Shehaby, RM. Emad, N. Martínez Moreno, R. Martínez Álvarez, D. Mathieu, A. Niranjan, LD. Lunsford, Z. Wei, RM. Shanahan, R. Liscak, J. May, A. Dono, AI. Blanco, Y. Esquenazi, S. Dayawansa, J. Sheehan, M. Tripathi, MJ. Shepard, RE. Wegner, R. Upadhyay, JD. Palmer, S. Peker
520    9_
$a BACKGROUND AND OBJECTIVES: Pleomorphic xanthoastrocytoma (PXA) is a rare low-grade glial tumor primarily affecting young individuals. Surgery is the primary treatment option; however, managing residual/recurrent tumors remains uncertain. This international multi-institutional study retrospectively assessed the use of stereotactic radiosurgery (SRS) for PXA. METHODS: A total of 36 PXA patients (53 tumors) treated at 11 institutions between 1996 and 2023 were analyzed. Data included demographics, clinical variables, SRS parameters, tumor control, and clinical outcomes. Kaplan-Meier estimates summarized the local control (LC), progression-free survival, and overall survival (OS). Secondary end points addressed adverse radiation effects and the risk of malignant transformation. Cox regression analysis was used. RESULTS: A total of 38 tumors were grade 2, and 15 tumors were grade 3. Nine patients underwent initial gross total resection, and 10 received adjuvant therapy. The main reason for SRS was residual tumors (41.5%). The median follow-up was 34 months (range, 2-324 months). LC was achieved in 77.4% of tumors, with 6-month, 1-year, and 2-year LC estimates at 86.7%, 82.3%, and 77.8%, respectively. Younger age at SRS (hazard ratios [HR] 3.164), absence of peritumoral edema (HR 4.685), and higher marginal dose (HR 6.190) were significantly associated with better LC. OS estimates at 1, 2, and 5 years were 86%, 74%, and 49.3%, respectively, with a median OS of 44 months. Four patients died due to disease progression. Radiological adverse radiation effects included edema (n = 8) and hemorrhagic change (n = 1). One grade 3 PXA transformed into glioblastoma 13 months after SRS. CONCLUSION: SRS offers promising outcomes for PXA management, providing effective LC, reasonable progression-free survival, and minimal adverse events.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a radiochirurgie $x metody $7 D016634
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a dospělí $7 D000328
650    12
$a astrocytom $x chirurgie $x radioterapie $7 D001254
650    12
$a nádory mozku $x chirurgie $7 D001932
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladiství $7 D000293
650    _2
$a mladý dospělý $7 D055815
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a dítě $7 D002648
650    _2
$a výsledek terapie $7 D016896
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Samanci, Yavuz $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey $u Department of Neurosurgery, Gamma Knife Center, Koc University Hospital, Istanbul , Turkey $1 https://orcid.org/0000000189526866
700    1_
$a Nabeel, Ahmed M $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Benha University, Benha , Egypt $1 https://orcid.org/0000000292178142
700    1_
$a Reda, Wael A $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt $1 https://orcid.org/0000000347235096
700    1_
$a Tawadros, Sameh R $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt $1 https://orcid.org/0000000281825375
700    1_
$a Abdelkarim, Khaled $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Clinical Oncology, Ain Shams University, Cairo , Egypt
700    1_
$a El-Shehaby, Amr M N $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Neurosurgery, Ain Shams University, Cairo , Egypt $1 https://orcid.org/0000000290759138
700    1_
$a Emad, Reem M $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo , Egypt $u Department of Radiation Oncology, National Cancer Institute, Cairo University, Cairo , Egypt
700    1_
$a Martínez Moreno, Nuria $u Radiosurgery Unit, Hospital Ruber Internacional, Madrid , Spain
700    1_
$a Martínez Álvarez, Roberto $u Radiosurgery Unit, Hospital Ruber Internacional, Madrid , Spain
700    1_
$a Mathieu, David $u Department of Neurosurgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke , Quebec , Canada
700    1_
$a Niranjan, Ajay $u Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh , Pennsylvania , USA $1 https://orcid.org/0000000167548597
700    1_
$a Lunsford, L Dade $u Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh , Pennsylvania , USA
700    1_
$a Wei, Zhishuo $u Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh , Pennsylvania , USA $1 https://orcid.org/0000000290911734
700    1_
$a Shanahan, Regan M $u Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh , Pennsylvania , USA $1 https://orcid.org/0000000258469966
700    1_
$a Liscak, Roman $u Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague , Czech Republic $1 https://orcid.org/0000000209298320
700    1_
$a May, Jaromir $u Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague , Czech Republic $1 https://orcid.org/000000019925338
700    1_
$a Dono, Antonio $u Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston , Texas , USA $1 https://orcid.org/0000000280418399
700    1_
$a Blanco, Angel I $u Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston , Texas , USA
700    1_
$a Esquenazi, Yoshua $u Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston , Texas , USA $1 https://orcid.org/0000000297571453
700    1_
$a Dayawansa, Samantha $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA $1 https://orcid.org/0000000222425187
700    1_
$a Sheehan, Jason $u Department of Neurological Surgery, University of Virginia, Charlottesville , Virginia , USA
700    1_
$a Tripathi, Manjul $u Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh , India $1 https://orcid.org/0000000256793439
700    1_
$a Shepard, Matthew J $u Department of Neurosurgery, Allegheny Health Network Cancer Institute, Pittsburgh , Pennsylvania , USA
700    1_
$a Wegner, Rodney E $u Department of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh , Pennsylvania , USA $1 https://orcid.org/0000000324163499
700    1_
$a Upadhyay, Rituraj $u Department of Radiation Oncology, The James Cancer Center, Ohio State University, Columbus , Ohio , USA $1 https://orcid.org/0000000340791268
700    1_
$a Palmer, Joshua D $u Department of Radiation Oncology, The James Cancer Center, Ohio State University, Columbus , Ohio , USA
700    1_
$a Peker, Selcuk $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey $u Department of Neurosurgery, Gamma Knife Center, Koc University Hospital, Istanbul , Turkey $1 https://orcid.org/0000000330573355
773    0_
$w MED00003511 $t Neurosurgery $x 1524-4040 $g Roč. 96, č. 2 (2025), s. 416-425
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38940575 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134749 $b ABA008
999    __
$a ok $b bmc $g 2311494 $s 1247226
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 96 $c 2 $d 416-425 $e 20240628 $i 1524-4040 $m Neurosurgery $n Neurosurgery $x MED00003511
LZP    __
$a Pubmed-20250415
Back

Find record

Citation metrics

Archiving options